Cargando…
Inhibition of ERK signaling for treatment of ERRα positive TNBC
Breast cancer is the second leading cause of cancer-related deaths in women and triple-negative breast cancer (TNBC), in particular, is an aggressive and highly metastatic type of breast cancer that does not respond to established targeted therapies and is associated with poor prognosis and worse su...
Autores principales: | Musheyev, David, Miller, Esther, Birnbaum, Natania, Miller, Elisheva, Erblich, Shoshana, Schuck, Alyssa, Alayev, Anya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171695/ https://www.ncbi.nlm.nih.gov/pubmed/37163498 http://dx.doi.org/10.1371/journal.pone.0283047 |
Ejemplares similares
-
Endocrine therapy resistance: what we know and future directions
por: Musheyev, David, et al.
Publicado: (2022) -
ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism
por: Berman, Adi Y, et al.
Publicado: (2017) -
The orphan receptor ERRα interferes with steroid signaling
por: Teyssier, Catherine, et al.
Publicado: (2008) -
The Asymmetric Binding of PGC-1α to the ERRα and ERRγ Nuclear Receptor Homodimers Involves a Similar Recognition Mechanism
por: Takacs, Maria, et al.
Publicado: (2013) -
Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells
por: Ghanbari, Faegheh, et al.
Publicado: (2020)